-+ 0.00%
-+ 0.00%
-+ 0.00%

ALUMIS - ON TRACK TO SUBMIT NDA FOR ENVUDEUCITINIB IN PSO TO FDA IN Q4 2026

Reuters·08/13/2026 20:01:01

Please log in to view news